Chennai Meenakshi Multispeciality Share Price Today | Stock Price & Chennai Meenakshi Multispeciality Share Screener
As of October 5, 2026, the live Chennai Meenakshi Multispeciality share price (BSE: CMMHOSP) is ₹36.79, up 0.49% from the previous close, with shares trading between ₹36.79 and ₹37.03 in today's trading session, and a 52-week range of ₹32.17–₹55.93. Check Chennai Meenakshi Multispecial yearly highs lows for the annual price range and momentum. Use the Chennai Meenakshi Multispeciality stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Chennai Meenakshi Multispeciality opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Chennai Meenakshi Multispeciality Share Price Chart
Track the current stock price of Chennai Meenakshi Multispeciality with an interactive chart. Analyse CMMHOSP share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Chennai Meenakshi Multispeciality stock quote in one place.
The quote of ₹36.79 sits between the 52-week low of ₹32.17 and the 52-week high of ₹55.93, and the latest session moved 0.49% from the previous close.
Chennai Meenakshi Multispeciality Company Profile - Fundamental Screener
Screen Chennai Meenakshi Multispeciality company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CMMHOSP shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE889F01017.
Company Details
Classification
Identifiers and Leadership
Chennai Meenakshi Multispeciality Balance Sheet Screener
Screen CMMHOSP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹21, down from ₹23 in 2025.
Latest statistics put total assets at ₹21 and shareholder funds at ₹-3.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 21 | 23 | 23 | 22 | 21 | 19 | 19 | 19 | 19 | 18 |
| Current Assets | 8 | 7 | 7 | 8 | 7 | 6 | 5 | 5 | 5 | 4 |
| Fixed Assets | 13 | 14 | 15 | 14 | 14 | 13 | 14 | 14 | 15 | 14 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 12 | 12 | 13 | 12 | 11 | 12 | 12 | 12 | 12 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | -3 | -2 | 0 | 0 | -1 | -5 | -4 | -4 | -4 | -6 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | -11 | -9 | -8 | -7 | -8 | -12 | -11 | -12 | -12 | -13 |
Chennai Meenakshi Multispeciality Income Statement Screener - Profit & Revenue Analysis
Screen Chennai Meenakshi Multispeciality income statement and profit fundamentals. Analyze CMMHOSP quarterly results. Chennai Meenakshi Multispeciality reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹38 and net profit was ₹0, equal to earnings per unit of ₹-0.60, at an operating margin of 2%.
In that period expenses were ₹37, interest cost ₹1 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹38 and net profit of ₹-1.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 38 | 38 | 36 | 39 | 39 | 32 | 20 | 27 | 23 | 24 | 19 | 21 | 19 |
| Expenses | 37 | 37 | 35 | 37 | 36 | 26 | 19 | 23 | 20 | 20 | 18 | 18 | 17 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 2 | 1 | 1 | 2 | 3 | 6 | 1 | 3 | 3 | 4 | 1 | 3 | 2 |
| Operating Profit % | 2.00% | -1.00% | -1.00% | 4.00% | 8.00% | 18.00% | 3.00% | 10.00% | 9.00% | 16.00% | 7.00% | 15.00% | 11.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | -1 | -1 | -1 | 0 | 1 | 4 | -1 | 1 | 0 | 2 | -1 | 1 | -1 |
| Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -1 | -1 | 0 | 1 | 4 | -1 | 1 | 0 | 2 | -1 | 1 | -1 |
| EPS | -0.60 | -1.50 | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 | 0.74 | 0.07 | 2.00 | -1.42 | 0.88 | -1.30 |
Chennai Meenakshi Multispeciality Cash Flow Screener - Liquidity Fundamentals
Screen CMMHOSP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹0, and net cash flow was an outflow of ₹2.
Over the same period, investing activities used ₹2 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 0 | 2 | 2 | 3 | 4 | 3 | 3 | 2 | 2 | 3 |
| Investing Activities | -2 | -1 | -2 | -2 | -2 | 0 | -1 | -1 | -2 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | -1 | -2 | 0 | -1 | -2 | -1 | -2 | -1 | -1 | -1 |
| Net Cash Flow | -2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | -1 | 1 |
Chennai Meenakshi Multispeciality Shareholding Pattern Screener
See Chennai Meenakshi Multispeciality shareholding pattern with promoter, FII, and DII holdings. Check Chennai Meenakshi Multispeciality promoter holding and ownership changes for CMMHOSP on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 57.10%, foreign institutions 0.00%, domestic institutions 0.14% and the public 39.83%, spread across 8,552 shareholders.
The shareholder count was 8,552 in 2026-Jun, compared with 8,540 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 57.10% | 57.10% | 57.10% | 57.10% | 57.10% | 57.10% | 57.10% | 55.78% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 39.83% | 39.83% | 39.83% | 39.79% | 39.57% | 39.23% | 39.15% | 39.80% |
| Other Holding | 2.93% | 2.93% | 2.93% | 2.97% | 3.19% | 3.53% | 3.60% | 4.28% |
| Shareholder Count | 8,552 | 8,540 | 8,549 | 8,671 | 8,625 | 8,633 | 8,708 | 8,659 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Chennai Meenakshi Multispeciality. Chennai Meenakshi Multispeciality dividend yield can be compared with peers and other stocks in the market.
Chennai Meenakshi Multispeciality Stock Index Membership - Nifty & Sensex
See which indices include Chennai Meenakshi Multispeciality stock. Check CMMHOSP index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Chennai Meenakshi Multispeciality Market Events Screener - Corporate Actions
Get Chennai Meenakshi Multispeciality corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Chennai Meenakshi Multispeciality stock events that may affect CMMHOSP share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 25, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -1.33% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 4.26% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 2.23% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | -0.66% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -10.97% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 11.16% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.88% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -6.92% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -18.49% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -0.86% |
| 2024-09-20 | 2024-09-20 | Annual General Meeting | NA | 10.63% |
| 2024-01-04 | 2024-01-04 | Extraordinary General Meeting | NA | 32.24% |
Chennai Meenakshi Multispeciality Competitors Screener - Peer Stocks Comparison
Screen CMMHOSP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 33,655 | 61.06 | 2,864 | 12.11% | 510 | 67.22 |
| Vijaya Diagnostic Centre | 14,708 | 78.93 | 835 | 19.34% | 173 | 41.15 |
| Metropolis Healthcare | 11,155 | 55.39 | 1,671 | 24.15% | 191 | 32.15 |
| Thyrocare Technologies | 8,493 | 48.36 | 846 | 20.48% | 163 | 36.09 |
| Nephrocare Health Services | 6,526 | 78.03 | 1,023 | 32.93% | 77 | 32.49 |
| Suraksha Diagnostic | 1,824 | 52.81 | 314 | 22.55% | 31 | 61.14 |
| Krsnaa Diagnostics | 1,800 | 18.63 | 816 | 9.90% | 101 | 51.22 |
| 3B BlackBio DX | 1,413 | 25.83 | 142 | 27.17% | 61 | 65.96 |
| One Global Service Provider | 1,027 | 13.97 | 499 | 237.48% | 70 | 42.95 |
| Health X Platform | 868 | -34.51 | 1,378 | 17.65% | -1 | 29.80 |
Chennai Meenakshi Multispeciality Company Announcements - News & Reports Screener
Screen CMMHOSP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 3, 2026 and October 2, 2026.
| Date | Update | Actions |
|---|---|---|
| Intimation For Regularization Of Appointment Of Independent Director And Secretarial Auditor At The Annual General Meeting Of The Company Held On September 30 2026 Under Regulation 30 Of SEBI (LODR) 2015 | - | |
| 2026-10-03 | Voting Results And Consolidated ScrutinizerS Report Submitted By Scrutinizer For E-Voting At 36Th Annual General Meeting. | - |
| 2026-10-02 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-10-01 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-10-01 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-08 | Intimation Of Cut-Off Date / Record Date For AGM Under Regulation 42 Of SEBI LODR Regulations 2015 | - |
| 2026-09-08 | Intimation Of Book Closure For Annual General Meeting Under Reg 42 Of SEBI LODR & Sec 91 Of Companies Act | - |
| 2026-09-08 | Reg. 34 (1) Annual Report. | - |
| 2026-09-08 | Intimation Under Regulation 30 And Regulation 36 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Notice Of 36Th Annual General Meeting | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-09-01 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On 1 September 2026 | - |
| 2026-08-27 | Update on board meeting | - |
| 2026-08-22 | Board Meeting Intimation for Fixing The Date Time And Mode/Venue For The 36Th AGM. Approval Of Boards Report Its Annexures And The Notice Of AGM For Year Ending March 31 2026. Book Closure Dates And Record Date/Cut Of Date For E-Voting Purposes. | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹36.79, within a 52-week range of ₹32.17 to ₹55.93. The P/E ratio is -66.55 and the P/B ratio is -8.89, with earnings per unit of ₹-1.50. Market capitalisation stands at ₹27.31 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.